1.04 -0.06 (-5.45%)

75.70% Fall from 52W High

1.1M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Reviva Pharmaceuticals Holdings Inc.

The latest disclosure was made by Narayan Prabhu in Reviva Pharmaceuticals Holdings Inc. where a trade of 194,250 Stock Option (right to buy) done was reported to US exchanges on Feb. 13, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Narayan Prabhu Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 194,250 194,250 - - Stock Option (right to buy)
Laxminarayan Bhat Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 181,500 181,500 - - Stock Option (right to buy)
Laxminarayan Bhat Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 519,000 519,000 - - Stock Option (right to buy)
Les Funtleyder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2024 8,200 8,200 - - Stock Option (right to buy)
Margolin Richard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2024 8,200 8,200 - - Stock Option (right to buy)
Saxena Parag Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2024 8,200 8,200 - - Stock Option (right to buy)
Purav Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2024 8,200 8,200 - - Stock Option (right to buy)
Narayan Prabhu Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2024 96,519 96,519 - - Stock Option (right to buy)
Laxminarayan Bhat Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2024 77,843 77,843 - - Stock Option (right to buy)
Laxminarayan Bhat Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2024 158,451 158,451 - - Stock Option (right to buy)
Narayan Prabhu Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2023 170,000 170,000 - - Stock Option (right to buy)
Laxminarayan Bhat Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2023 150,000 150,000 - - Stock Option (right to buy)
Laxminarayan Bhat Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2023 443,000 443,000 - - Stock Option (right to buy)
Purav Patel Director Purchase of securities on an exchange or from another person at price $ 4.69 per share. 18 Nov 2022 3,000 43,547 - 4.7 14,070 Common Stock, par value $0.0001 per share
Purav Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 3,900 3,900 - - Stock Option (right to buy)
Richard Margolin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 3,900 3,900 - - Stock Option (right to buy)
Les Funtleyder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 3,900 3,900 - - Stock Option (right to buy)
Parag Saxena Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 3,900 3,900 - - Stock Option (right to buy)
Narayan Prabhu Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.66 per share. 30 Sep 2022 50,000 100,000 - 1.7 83,000 Common Stock, par value $0.0001 per share
Narayan Prabhu Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.21 per share. 30 Jun 2022 50,000 50,000 - 1.2 60,670 Common Stock, par value $0.0001 per share
Purav Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 5,300 5,300 - - Stock Option (right to buy)
Richard Margolin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 5,300 5,300 - - Stock Option (right to buy)
Les Funtleyder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 5,300 5,300 - - Stock Option (right to buy)
Parag Saxena Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 5,300 5,300 - - Stock Option (right to buy)
Parag Saxena Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,000 4,000 - - Stock Option (right to buy)
Purav Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2021 15,227 15,227 - - Stock Option (right to buy)
Narayan Prabhu Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2021 50,000 50,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures